QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 

   

 

Health Affairs, 27, no. 6 (2008): 1466
doi: 10.1377/hlthaff.27.6.1466
© 2008 by Project HOPE
 
New Online
 * Senate Health Reform Bill
 * Rewarding Providers
 * Public Option Policy Brief
 * Health Reform & Abortion
 * Delivery System Reform
This Article
* Extract Freely available
* Reprint (PDF)
* Erratum
* Submit a response to this article
* Alert me when this article is cited
* Alert me when Comments are posted
* Alert me if a correction is posted
Services
* E-mail this article to a friend
* Similar articles in this journal
* Alert me to new issues of the journal
* Add to My Personal Archive
* Download to Citation Manager
*Reprints & Permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Search for Related Content
Related Collections
* Research And Technology

Imaging Boom

PROLOGUE

The Imaging Boom


Advanced medical imaging includes such technologies as computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET). These technologies clearly represent an unparalleled diagnostic advance, since they afford the chance to see into the body with relatively little risk. But as the papers in this section make clear, the equipment is proliferating and the volume of imaging exploding. Laurence Baker and colleagues observe that there are now more than 7,000 U.S. sites offering MRI, with state-of-the-art machines costing more than $2 million apiece. At Group Health Cooperative in Washington State, we learn from Rebecca Smith-Bindman and colleagues, MRI scans tripled in the decade from 1997 through 2006.

Nationwide, an estimated twenty-six million MRIs are now performed annually—on average, more than 173 for each and every Medicare beneficiary. Each additional machine drives the number of procedures upward; every new CT unit, for example, averaged more than 2,200 new procedures per year in 1995–2004.

This imaging boom raises myriad critical questions for patients, providers, and payers—many of them clustered around the topic of whether we’re getting enough value for the dollars spent. Are these technologies overused or appropriately used—and under what circumstances, for which patients? How much imaging should we perform and pay for if the main benefit is additional information—for example, learning that you don’t have a brain tumor—and not necessarily quantifiable improvements in real health outcomes? Are payers like Medicare overcompensating providers for doing these scans? What should be done about the apparent conflicts of interest inherent in physicians’ having their own in-office advanced imaging equipment, since each additional CT unit in a physician’s practice is associated with about $685,000 in additional spending per year?

The authors of the papers in this section explore these questions in depth. Ariel Winter and Nancy Ray analyze Medicare’s considerations in deciding how much to pay; they conclude that flaws in those formulas could be fueling the imaging boom. Steven Pearson and colleagues describe challenges in evaluating imaging’s comparative effectiveness, given such factors as rapid changes in imaging techniques and differences in providers’ diagnostic skills. They produce a case study of CT colonography, commonly known as "virtual colonoscopy," and tell how their group at Massachusetts General Hospital’s Institute for Clinical and Economic Review evaluated such factors as radiation risk. They also offer perspective on how evidence reviewers can better assess these technologies going forward.


Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati    What's this?




Home | Current Issue | Archives | Topic Collections | Search | Blog | Subscribe | Contact Us | Help

© 2001-2008 Project HOPE–The People-to-People Organization
Terms and Policies